TransMedics Group, Inc.

For the period ended Mar 31, 2026. Filed May 5, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 5, 2026

TMDX$93.79+6.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)

	March 31,	December 31,
	2026	2025
Assets
Current assets:
Cash	$461,739	$488,366
Accounts receivable	90,727	84,282
Inventory	49,890	48,881
Prepaid expenses and other current assets	16,924	16,254
Total current assets	619,280	637,783
Property, plant and equipment, net	361,571	327,656
Finance lease right-of-use assets, net	334,545	—
Operating lease right-of-use assets, net	4,858	5,155
Deferred tax assets	82,476	83,543
Restricted cash	18,438	500
Goodwill	11,549	11,549
Acquired intangible assets, net	—	1,948
Other non-current assets	2,103	239
Total assets	$1,434,820	$1,068,373
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$11,151	$10,350
Accrued expenses and other current liabilities	59,316	62,740
Current portion of long-term debt	15,000	10,000
Deferred revenue	2,945	2,905
Operating lease liabilities	3,508	3,310
Total current liabilities	91,920	89,305
Convertible senior notes, net	453,530	452,804
Long-term debt, net	44,665	49,587
Finance lease liability	343,829	—
Operating lease liabilities, net of current portion	2,883	3,577
Other long-term liabilities	3,986	—
Total liabilities	940,813	595,273
Commitments and contingencies (Note 10)
Stockholders’ equity:
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	—	—
Common stock, no par value; 150,000,000 shares authorized; 34,545,721 shares and 34,267,802 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	764,640	750,926
Accumulated other comprehensive income	2	124
Accumulated deficit	(270,635)	(277,950)
Total stockholders’ equity	494,007	473,100
Total liabilities and stockholders’ equity	$1,434,820	$1,068,373

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.